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Nectin and nectin-like proteins are cell adhesionmol-
ecules that mediate the formation of cell adherens
junctions by forming homo- or heterodimers. Some
members of this protein family can also be used by
immune receptors to mediate immune recognition.
For instance, nectin-like 2 (Necl-2) is used as a ligand
for the immune system by interaction with the im-
mune receptor CRTAM (class-I MHC-restricted
T cell associated molecule), which is mainly ex-
pressed on the surface of cytotoxic lymphocyte
cells. However, the Necl-2/CRTAM binding mode
and its relationship to cell adhesion are not known.
Here, we report a Necl-2/CRTAM complex structure,
demonstrating that Necl-2 binding to CRTAM com-
petes with the dimerization of CRTAM and possibly
Necl-2. Necl-2 occupies the CRTAM homodimer
interface, making homodimerization impossible.
Mutational and functional analyses identified key
amino acids (double ‘‘lock-and-key’’) responsible
for the binding. Our work illustrates how the cell
adhesion molecule Necl-2 competitively binds the
immune receptor CRTAM.
INTRODUCTION
Molecular recognition of cytotoxic lymphocytes, including CD8+
cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells, to
their target cells is mediated by the interaction of their cell sur-
face receptors with their cognate ligands (Lanier, 2005; van der
Merwe and Dushek, 2011). It is believed that binding of NK cell
receptors to their ligands is antigen nonspecific, but CD8+
CTLs depend on peptide-bound major histocompatibility com-
plex (MHC) class I interactions with T cell receptors (TCRs)
with the assistance of coreceptors and costimulatory molecules
(e.g., CD8, CD4, and CD28; Lanier, 2005; van der Merwe and
Cordoba, 2011; Zou and Chen, 2008). The molecular recognition
of NK cells and CD8+ CTLs to their target cells has been revealed1430 Structure 21, 1430–1439, August 6, 2013 ª2013 Elsevier Ltd Alby many complex structures between the receptors and ligands
as summarized in several reviews (Chen et al., 2009; Garcia and
Adams, 2005). However, many such complexes have yet to be
crystallographically determined (Chan et al., 2012; Vivier et al.,
2008). Moreover, many receptor/ligand pairs are still unidenti-
fied. For instance, CRTAM (class-I MHC-restricted T cell associ-
ated molecule) is a recently identified receptor expressed on the
surfaces of both NK cells and CD8+ CTLs that interacts with nec-
tin-like 2 (Necl-2; Arase et al., 2005; Boles et al., 2005; Galibert
et al., 2005).
CRTAM is expressed on the lymphocyte surface only upon cell
activation (Kennedy et al., 2000). Functional cell-based and
knockout mouse work demonstrated that CRTAM promotes
CD8+ CTL and NK cell adhesion to their target cells (Boles
et al., 2005; Takeuchi et al., 2009), as well as facilitates CD4+
T cell polarity and adhesion for the cells to produce more inter-
feron gamma and interleukin-22 (Yeh et al., 2008). Furthermore,
decreased expression of Necl-2 on the surface of some tumor
cells is an escape mechanism of tumor killing. Therefore, it is
believed that CRTAM plays an important role in tumor cell killing
by both NK cells and CD8+ CTLs (Boles et al., 2005).
Necl-2 belongs to the Nectin and nectin-like (Necl) proteins
that are cell adhesion molecules (CAMs) characterized by an
immunoglobulin (Ig)-like nature with three Ig-like domains (Takai
et al., 2008). There are ninemembers in this group of CAMs: nec-
tin-1, -2, -3, and -4; and Necl-1, -2, -3, -4, and -5 (Takai et al.,
2008). As the only ligand identified for CRTAM, Necl-2 is mainly
expressed in two types of cells, dendritic cells (DCs) and epithe-
lial cells, indicating its functions in both immune regulation and
cell adhesion (Galibert et al., 2005; Garay et al., 2010; Takeuchi
et al., 2009).
In addition to its interaction with CRTAM, Necl-2 also binds to
Necl-1 and nectin-3 (Shingai et al., 2003). It was named cell
adhesion molecule 1 (Cadm1) due to its ability to facilitate cell-
cell adhesion in different tissues (Ito et al., 2008). It is also called
TSLC1 (tumor suppressor in lung cell-1) because it is inactivated
in non-small-cell lung cancer cells (Murakami, 2005). Yet another
name for Necl-2 is synaptic cell adhesion molecule (SynCAM1),
which is for its function in neurologic synapse formation (Bie-
derer et al., 2002). Other names used for Necl-2 include IGSF4,
RA175, and SgIGSF (Gomyo et al., 1999; Urase et al., 2001; Wa-
kayama et al., 2001). This diverse nomenclature stronglyl rights reserved
Figure 1. Overall Structure of the Necl-2v/CRTAMv Complex
(A) Schematic representations of human Necl-2 and CRTAM. Signal peptides,
and transmembrane and extracellular regions are shown as white, hatched
boxes, and open circles, respectively. Residue numbers are based on the
mature proteins.
(B) The complex structure of the of Necl-2v (green) bound to CRTAMv (cyan).
The b strands are labeled as in the IgV fold. The parenthesizedC00 highlights the
fact that both Necl-2v and CRTAMv lack the C00 strand of a canonical IgV
structure, with the corresponding residues forming a loop instead. The protein
termini are labeled. The magenta sticks represent potential N-glycosylation
sites.
Table 1. Data Collection and Refinement Statistics
Necl-2v/CRTAMv
Data Collection
Space group P61
Cell Dimensions
a, b, c (A˚) 91.0, 91.0, 56.7
a, b, g () 90.0, 90.0, 120.0
Wavelength (A˚) 1.00000
Resolution (A˚)a 50.0–1.7 (1.76–1.70)
Rsys or Rmerge
a,b 0.063 (0.416)
I/sIa 59.25 (10.10)
Completeness (%)a 100.0 (100.0)
Redundancya 22.5 (22.4)
Total reflections 667,825
Unique reflections 29,635
Refinement
Resolution (A˚) 29.8–1.70
Rwork/Rfree
c 0.165/0.207
No. atoms
Protein 1,565
Water 374
B-factors
Protein 17.7
Water 36.2
Rmsd
Bond lengths (A˚) 0.006
Bond angles () 1.095
Ramachandran plotd
Most favored region (%) 86.6
Additionally allowed region (%) 11.7
Generously allowed region (%) 1.7
Disallowed region 0
aValues for the outmost resolution shell are given in parentheses.
bRmerge = SiShkl j Ii  < I > j /SiShklIi, where Ii is the observed intensity
and < I > is the average intensity from multiple measurements.
cRwork = S j j Fo j  j Fc j j /S j Fo j, where Fo and Fc are the structure-factor
amplitudes from the data and themodel, respectively. Rfree is the R factor
for a subset (5%) of reflections that was selected prior to refinement cal-
culations and was not included in the refinement.
dRamachandran plots were generated with PROCHECK.
Structure
Complex Structure of CRTAM with Nectin-like 2indicates the multiple functions of Necl-2 in cell-cell interactions.
The molecular basis for such a molecule to interact with itself
(homodimer) or other molecules (heterodimer) is also an inter-
esting conundrum, which is the subject of this study.
Here, we report the complex structure of Necl-2 with CRTAM,
demonstrating that the heterodimeric interaction competes with
CRTAM and Necl-2 homodimerizations. Therefore, our work de-
picts the molecular exploitation of the immune receptor CRTAM
by the cell adhesion molecule Necl-2.
RESULTS
Overall Structure of the Necl-2v/CRTAMv Complex
Necl-2 and CRTAM are typical type I transmembrane proteins
with either three (one V-set and two C-sets) or two (one V-set
and one C-set) extracellular Ig-like domains, respectively (Fig-
ure 1A). Potent binding between Necl-2 and CRTAM has been
demonstrated in several previous studies (Arase et al., 2005;
Boles et al., 2005; Galibert et al., 2005). The N-terminal IgV
domains of the respective molecules (Necl-2v and CRTAMv)
are proposed as the main interacting sites involved in the
binding (Arase et al., 2005). Therefore, in this study, we ex-
pressed the IgV domains of both proteins as inclusion bodiesStructure 21, 1430and successfully obtained the hetero-complex by co-refold-
ing. The structure was solved at a resolution of 1.7 A˚
(Table 1).
One molecule of each of the two proteins is present in the
asymmetric unit. For the complex structure, clear electron den-
sity could be observed for Necl-2 amino acids Q1 to P100 and
CRTAM residues H5 to T100. In each molecule, the amino acids
are arranged into an eight-stranded barrel with two b sheets of
five (ACC0FG) and three (BED) strands, respectively (Figure 1B).
This fold is different from the canonical nine-stranded IgV struc-
ture of a 5 + 4 (CC0C00FG+ABED) pattern as represented by anti-
body variable domains (Bork et al., 1994). Nevertheless, some
V-set Ig-like structures display a 6 + 3 (ACC0C00FG+BED)–1439, August 6, 2013 ª2013 Elsevier Ltd All rights reserved 1431
Figure 2. Biophysical Characterization of
the Three Protein Species
(A) Analytical gel filtration of CRTAMv (black),
Necl-2v (blue), and the Necl-2v/CRTAMv complex
(red). The 280-nm absorbance curves and the
SDS-PAGE migration profiles of the pooled sam-
ples are shown.
(B) Ultracentrifugation sedimentation profile of
CRTAMv.
(C) Sedimentation profile of the Necl-2v/CRTAMv
complex. The calculated molecular weight of the
indicated protein species is shown.
(D) Binding affinity between Necl-2v and CRTAMv
measured by SPR. The dynamic binding of
CRTAMv (concentration gradient) to immobilized
Necl-2v is shown. Fits overlaid on our measured
data were provided in the form of dashed gray
lines. The dissociation constant (Kd) of the Necl-
2v/CRTAMv complex was calculated to be
12.5 mM.
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Complex Structure of CRTAM with Nectin-like 2arrangement, with some rare cases in which the C00 strand
is missing from the fold (Bork et al., 1994). Therefore, the first
domains of both Necl-2 and CRTAMexhibit an IgV-like structure,
consistent with previous predictions. Thus, in this study, we
termed the respective proteins Necl-2v and CRTAMv,
respectively.
Overall, Necl-2v and CRTAMv are joined via the ACC0FG
sheet. The two molecules exhibit great structural similarities,
with a root mean square deviation (rmds) of only 0.72 A˚ for 84
equivalent Ca pairs (Figure 1B). There are three and four pre-
dicted N-glycosylation sites in CRTAMv and Necl-2v, respec-
tively (Figure 1A). None of these sites are in the proximity to the
binding interface of the two proteins and, thus, would not inter-
fere with the interaction. It should also be noted that within the
structure of the hetero-complex, the C termini of Necl-2v and
CRTAMv point in divergent directions, corresponding well to a
trans binding mode of the two proteins between two neighboring
cells.
A 1:1 Binding Mode of Necl-2 and CRTAM
With only a single Necl-2v and CRTAMvmolecule per AU (see re-
sults above), the complex structure strongly indicates a 1:1 bind-
ing mode between the two proteins. We therefore analyzed the
free CRTAMv and Necl-2v, and the Necl-2v/CRTAMv complex
with analytical gel filtration to further verify the observed binding
stoichiometry. On a calibrated Superdex 75 column (10/300 GL),
CRTAMv eluted as a main peak at 13.2 ml combined with a
shoulder at 12.0 ml, indicating the presence of both monomers
and dimers in solution (Figure 2A). Further ultracentrifugation
sedimentation analysis confirms themonomer/dimer equilibrium
for CRTAMv (Figure 2B). This result is also consistent with a
recently deposited but unreported IgV domain structure of
CRTAM (Protein Data Bank [PDB] code: 3RBG), which is dimeric1432 Structure 21, 1430–1439, August 6, 2013 ª2013 Elsevier Ltd All rights reservedin the crystals. In contrast, Necl-2v elutes
as a single peak with an elution volume of
approximately 11.7 ml on the column
(Figure 2A). The apparent molecular
weight (MW) of this protein species was
30 kDa, corresponding well to a dimer.
The extremely low refolding efficiency for Necl-2v precluded
sedimentation analysis. Nevertheless, the observance of a
Necl-2v dimer is consistent with a multiple line of previous re-
ports of dimeric structures for members of the same family,
such as nectin-1, nectin-2, Necl-1, and mouse Necl-3, which
all indicate the involvement of their N-terminal IgV domains in
the homodimerization (Dong et al., 2006; Fogel et al., 2010; Liu
et al., 2012; Narita et al., 2011).
The elution volume of the hetero-complex was almost the
same as those observed for the Necl-2v and CRTAMv dimers
(Figure 2A). Accordingly, the sedimentation assay revealed a sin-
gle protein species of approximately 23 kDa (Figure 2C). These
results clearly show that one Necl-2v protein in combination
with a single CRTAMv molecule form a heterodimer in solution,
which corresponds with the complex composition observed in
the crystals. Therefore, the biophysical data also support a 1:1
binding mode between Necl-2v and CRTAMv.
The potent binding between Necl-2v and CRTAMv was next
analyzed in vitro by surface plasmon resonance (SPR). CRTAMv
quickly associates with, but slowly dissociates from, the immo-
bilized Necl-2v (Figure 2D). The dissociation constant (Kd) be-
tween the two proteins was calculated to be 12.5 mM, with
kon = 6.273 10
2 M1s1 and koff = 7.843 10
3 s1, respectively.
A Double ‘‘Lock-and-Key’’ Binding Mode between Necl-
2v and CRTAMv
Facilitated by the high-resolution structure of the Necl-2v/
CRTAMv complex, we further characterized the binding between
these two proteins by systematically investigating specific amino
acid interactions. Extremely good complementarities in both
shape and hydrophobicity were observed between the two inter-
acting molecules, defining a double ‘‘lock-and-key’’ binding
manner. Scrutinizing the interface in Necl-2v revealed two
Figure 3. A Double Lock-and-Key Binding
Mode between Necl-2v and CRTAMv
(A–C) The interface residues in Necl-2v (light gray
surface) form two lock-like (lock 1 and 2) hydro-
phobic patches to accommodate the two key-like
residues (key 1 and 2) of CRTAMv (cyan ribbon).
An overview of the two locks in Necl-2v (A). The
magnified views of the lock 1 (B) and lock 2 (C)
patches to highlight the interaction details.
(D–F) Reciprocally, the Necl-2v (green ribbon)
binding site within CRTAMv (dark gray surface) is
composed of an extended surface patch with two
pockets of strong hydrophobicity and a small extra
apolar patch. The two pockets complementarily
accommodate Necl-2v F39 and Y83, defining an
interaction of a double-hole lock with a double-
lever key. The surface patches referred to in the
text are highlighted in yellow. All of the residues
involved are labeled and shown in stick repre-
sentation. Dashed lines indicate H-bonds. Over-
view of the Necl-2v binding site in CRTAMv (D).
Details of the double-hole lock/double-lever key
interaction (E). Contacts at the extra CRTAMv
patch (F).
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Complex Structure of CRTAM with Nectin-like 2separate lock-like surface patches, contacting the C/C0 and F/G
intervening loops of CRTAMv, respectively (Figure 3A). Lock1 in-
volves Y83 and the apolar carbon atoms of S28, P47, E89, and
Q81, suitably accommodating the protruding residue F39
(key1) of CRTAMv. Additional interactions at this site involve
three interchain hydrogen bonds formed among S28, Q31, and
Y83 of Necl-2v and T40 and K50 of CRTAMv (Figure 3B). The
second patch (lock2) is composed of residues P47 and L48
and the apolar carbons fromQ38 and T39, complementarily con-
tacting Y84 (key2) of CRTAMv (Figure 3C). As with lock1, lock2
also provides three H-bond interactions with CRTAMv These
include two H-bond contacts provided by Necl-2v T39 with
CRTAMv Q32 and Y84 and an extra contact by Necl-2v K49
with CRTAMv N28 (Figure 3C).
Reciprocally, the interface within CRTAMv could also be
divided into two parts (Figure 3D). The first part is an extended
surface patch consisting of amino acids F39, T40, L43, Y46,
P47, A48, L49, and K50. These residues form two pockets of
strong hydrophobicity, defining a ‘‘double-hole lock.’’ The
Necl-2v residues F42 and Y83 insert their side chains into the
two pockets, and thereby functioning as a ‘‘double-lever key’’
(Figure 3E). The second part is much smaller than the first and in-
volves only three residues: L82, Y84, and L88. This apolar patch
contributes to the intermolecular interactions by stacking against
Necl-2v residues P47 and L48 and providing an H-bond by res-
idue N28 with Necl-2v K49 (Figure 3F).
Mutagenesis Analysis
We next set out to investigate the importance of the structurally
defined contact residues in hetero-complex formation. Encoun-
tering problems with the refolding of Necl-2v, we instead
performed alanine-scanning mutagenesis of CRTAMv. Four res-
idues, including F39 and Y84 (two key-like residues) and T40 and
K50 (two H-bond forming residues), were substituted by Ala
either individually or together. Our SPR result clearly shows
that individual mutation of these four residues did not abolish
binding but all resulted in decreased binding. In contrast, theStructure 21, 1430quadruple mutant minimally bound Necl-2v (Figure 4A). We
further compared the binding capability of the respective
CRTAMv proteins to cell surface-expressed full-length Necl-2
by flow cytometry with phycoerythrin-conjugated CRTAMv tet-
ramers. With a specific Necl-2 antibody, consistent expression
pattern as in previous reports is observed in P815 (none), A549
(basal), and NCl-H522 (abundant) cells (Yageta et al., 2002). In
addition, 293T cells also expressed large amounts of Necl-2 (Fig-
ure 4B). Accordingly, the wild-type CRTAMv tetramer bound to
293T and NCl-H522 cells rather than P815 cells, with weaker
binding to A549 cells. Besides, transfection of P815 cells with
a Necl-2 expressing plasmid resulted in potent surface-binding
of CRTAMv tetramer (Figure 4C). These results demonstrated
the location of CRTAMv on the surface of 293T, NCl-H522, and
A549 cells due to the CRTAMv-mediated interaction with Necl-
2. Hereafter, we used only 293T for further analysis with the
mutant tetramers. Consistent with the SPR assay, all of the single
CRTAMv mutations showed reduced binding to Necl-2, and the
quadruple Ala substitution largely abrogated the Necl-2/CRTAM
interaction (Figure 4D). The wild-type CRTAMv protein strongly
blocked the binding of CRTAMv tetramer to HEK293T cells,
while an irrelevant GST protein or the quadruple mutant FTKY
did not interfere with this interaction (Figure 4E). Together, the
mutagenesis assay supports our structural analysis by confirm-
ing the involvement of F39, T40, K50, and Y84 in the interaction
of CRTAMv with Necl-2.
Competition between Hetero- and Homodimers
Because both CRTAMv and Necl-2v form homodimers in solu-
tion (see results above), it is an interesting issue to investigate
the relationship between the hetero-complex and either of the
two homodimers.We first compared our structure with a recently
deposited dimeric free-CRTAMv structure (PDB code: 3RBG).
Unexpectedly, the same ACC0FG sheet in the CRTAMv protein
was revealed as the structural elements contacting its ligand
(Necl-2v or another CRTAMv molecule; Figures 5A and 5B).
The CRTAMv footprints were then determined by selection of–1439, August 6, 2013 ª2013 Elsevier Ltd All rights reserved 1433
Figure 4. Mutagenesis of the Interface Residues in CRTAMv Reduces Its Binding to Necl-2v
The mutant CRTAMv proteins (dubbed F39A, T40A, K50A, Y84A, and FTKY, respectively) were compared withWT CRTAMv for their binding capabilities to either
immobilized Necl-2v (by SPR) or cell-surface-expressed Necl-2 (flow cytometry).
(A) Individual CRTAMv proteins (100 mM mutant or WT) passed through flow cells immobilized with Necl-2v. The kinetic profiles are shown.
(B) Western blot screening of 293T, NCl-H522, A549, and P815 cells for the expression of Necl-2 using a Necl-2 polyclonal antibody. b-actin was selected as the
loading control.
(C) Cell surface binding of theWT CRTAMv tetramer tested by flow cytometry. TheWT tetramer could bind to endogenously Necl-2-expressing (293T, A549, and
NCI-H522) cells, Necl-2-transfected (P815-Necl-2) cells, but not to Necl-2-negative (P815) cells. Shaded histogram: PE-conjugated streptavidin; unfilled his-
togram: CRTAMv tetramer.
(D) Flow cytometric analysis of the 293T cell binding by the Necl-2 antibody, WT CRTAMv tetramer, or the individual mutant tetramers, as indicated. Shaded
histogram: PE-conjugated streptavidin; unfilled histogram: indicated tetramers.
(E) Flow cytometric analysis of the 293T cell binding by WT CRTAMv tetramer after blocking with the indicated proteins. Shaded histogram: PE-conjugated
streptavidin; unfilled histogram: CRTAMv tetramer.
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Complex Structure of CRTAM with Nectin-like 2the residues within a 4.5 A˚ distance from the contacting ligands.
A total of 22 amino acids were revealed for the hetero-complex,
forming an extended surface patch of843 A˚2 in the buried area.
For the CRTAMv homodimer, this footprint includes 16 residues,
all of which are also involved in the interaction with Necl-2v (Fig-
ure 5C). Therefore, Necl-2 binding will compete with CRTAM
dimerization. It is also notable that six additional CRTAM resi-
dues (K25, L34, S37, N44, Y46, and P47) were observed in the
hetero-complex interface, leading to an 14% increase in the
buried surface area compared to the homodimer interface.1434 Structure 21, 1430–1439, August 6, 2013 ª2013 Elsevier Ltd AlThis may indicate an advantage of Necl-2 in the competition
for CRTAM molecules during cell-cell interactions.
Without a free-Necl-2v structure, we managed to model a
dimeric structure for Necl-2v using the mouse Necl-3 structure
(PDB code: 3M45) as a reference. Of all the nectins and Necls,
Necl-3 most resembles Necl-2 in sequence (>40% identity for
the first IgV domain), structure (revealed by a Dali search [Holm
and Rosenstro¨m, 2010] within the PDB using the single Necl-2v
chain in our complex structure as the input probe) and functions
(both involved in neurologic synapse formation and sharingl rights reserved
Figure 5. Competition of Heterodimer with Homodimers
(A–C) Necl-2v binding competes with CRTAMv dimerization. CRTAMv is
shown in surface representation (light gray), and its interacting molecules of
Necl-2v or another CRTAMv are presented in cartoon representation and
colored green and cyan, respectively. The CC0FG sheet of CRTAMv is high-
lighted in blue and labeled. Necl-2v/CRTAMv heterodimer (A). CRTAMv ho-
modimer (B). Comparison of the ligand footprints in CRTAMv (C). The homo-
dimer interface of CRTAMv includes 16 residues (yellow), and six extra
residues are involved in the heterodimer interface (orange).
(D and E) CRTAMv binding competes against Necl-2 heterophilic interaction.
Superimposition of the modeled Necl-2v homodimer structure (D, magenta)
onto that of the Necl-2v/CRTAMv complex (green for Necl-2v and cyan for
CRTAMv). The same interface in Necl-2v for both hetero- and homodimeri-
zation is revealed (E).
Figure 6. CRTAMv-Mediated Inhibition of Cell Conjugate Formation
A representative picture of the flow cytometric analysis of cell conjugates and
quantification of cell conjugate percentage in three independent experiments.
293T cells were treated as described in the Experimental Procedures for
separate dye-labeling with PKH26 and CFSE, and the proteins (GST, CRTAMv
WT, and FTKY mutant) at indicated concentrations were added to the cells for
Necl-2 blockage. The PHK26 labeled cells were thenmixedwith CFSE-labeled
cells and analyzed with flow cytometry. The percentage of the double-
signaling cell fraction was shown. Error bars in the histogram represent the SD
from the mean of three independent experiments.
See also Figure S1.
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Complex Structure of CRTAM with Nectin-like 2similar nomenclature as SynCAMs; Takai et al., 2008). Therefore,
a similar homodimerization mode as observed in the mNecl-3v
structure could be expected for Necl-2v. Within this model,
Necl-2v utilizes the same CRTAMv contacting patch to interact
with another Necl-2v molecule (Figure 5D), indicating a potential
competition of Necl-2v homodimerization with its heterodimeri-
zation with CRTAMv. We further carried out a cell conjugate
assay to visualize this competitive relationship. The 293T cells
were separately stained with PKH26 and CFSE, and then mixed
and incubated to allow the formation of cell conjugates. The dou-
ble-stained cells were analyzed by flow cytometry. Necl-2 con-
tributes to conjugate formation, knockdown of which by siRNA
led to an30%decrease in the frequency of double-stained cells
(Figure S1 available online). Wild-type (WT) CRTAMv, but not the
CRTAMvquadruplemutant orGlutathioneS-transferase (an irrel-
evant protein), dramatically inhibited cell conjugates of 293T
mediated by the homophilic interactions of Necl-2 (Figure 6).
DISCUSSION
In this study, we solved the complex structure between CRTAMv
and Necl-2v. Although our structure only includes the IgV do-
mains of both molecules, interactions between other domainsStructure 21, 1430of the two molecules (e.g., between the CRTAM IgC and two
Necl-2 IgCs) is predicted to be difficult due to the nearly perpen-
dicular heterodimeric arrangement of this interaction. In accor-
dance, a previous study demonstrates that the IgV domains
alone are able to mediate the interaction between CRTAM and
Necl-2 (Arase et al., 2005). Nevertheless, the authors from the
same report also observe that excluding the IgC domains from
either CRTAM or Necl-2 results in a decreased binding affinity
compared to the full-length proteins (Arase et al., 2005). There-
fore, with a predominant Necl-2/CRTAM interaction contributed
by theN-terminal IgV domains, the IgC domains of the respective
molecules also somehow facilitate binding. We noted that the
linker length between the first and second Ig-like domains of
CRTAM and Necl-2 are assumed to be 6 and 18 amino acids
(from secondary structure prediction), respectively. A long
domain-linker in Necl-2 might enable the molecule to swing its
second IgC domain back to interact with CRTAM IgC. In this
case, hinge region flexibility between the Ig-like domains, which
has been reported in other molecules (Chen et al., 2010; Zhang
et al., 2011), might be a prerequisite. The detailed involvement
of other domains in the Necl-2/CRTAM interaction should be
tested in the future with the complex structure of the full-length
proteins.
We also characterized the binding kinetics between CRTAMv
and Necl-2v. The affinity between these two molecules was–1439, August 6, 2013 ª2013 Elsevier Ltd All rights reserved 1435
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Complex Structure of CRTAM with Nectin-like 2calculated based on a 1:1 Langmuir binding mode. However,
both proteins have the tendency to form dimers in solution.
The homodimerization of proteins in immobilized and mobile
phases would hinder the accurate measurement of the binding
affinity. Similar problems have been discussed previously (Harri-
son et al., 2012; Mavaddat et al., 2000). Therefore, the true bind-
ing affinity between CRTAMv and Necl-2v might be lower than
the one determined with the Langmuir model. Nevertheless,
the generated model-curve using such an algorithm fits the
experimental data well, indicative of at least partial rationality
for the calculated dissociation constant.
Our results also demonstrated that the Necl-2/CRTAM
heterodimeric interaction disrupts CRTAMhomodimer formation
because both complexes utilize the same binding interface. For
Necl-2, self-interaction of the molecule on the cell surface has
been demonstrated in several previous studies (Fogel et al.,
2010; Masuda et al., 2002; Shingai et al., 2003). Based on homol-
ogy modeling, the Necl-2 IgV domain would likely form a similar
homodimer structure. Therefore, the Necl-2/CRTAM hetero-
dimer interaction should compete with Necl-2 dimerization as
well. Accordingly, in a cell-based assay, CRTAM indeed com-
petes against the Necl-2 heterophilic interaction, disrupting
Necl-2-mediated cell adhesion. Thus, we propose a com-
petition model between immune cell molecular recognition and
cell adhesion in the Necl protein family. We further calculated
the shape complementarity for CRTAMv, CRTAMv/Necl-2v,
and the modeled Necl-2v dimers using an sc program in CCP4
(CCP4, 1994). The complementary statistics of the three mole-
cule pairs above are 0.626, 0.709, and 0.488, respectively.
Clearly, CRTAM is much better complementary to Necl-2 than
another Necl-2 molecule. In terms of CRTAMv homodimer and
CRTAMv/Necl-2v heterodimer, the difference in shape com-
plementarity is not significant. Nevertheless, the buried interface
area of the latter is approximately 14% larger than that of the
former dimer pair, giving priority to hetero-complex formation
over CRTAM homodimerization. Thus, we believe that the
interaction between Necl-2 and CRTAM is preferred over the ho-
mophilic contacts in the homodimers of either molecules.
Accordingly, during the in vitro co-refolding of CRTAMv and
Necl-2v, we always obtained heterodimers rather than either of
the homodimers. These results support the feasibility of our
competition model.
In addition to immune cell surface expression, CRTAM is also
expressed on the surface of epithelial cells (Garay et al., 2010).
Despite the fact that CRTAM is categorized into the junction ad-
herens molecule (JAM) family, Garay and colleagues pointed out
that CRTAMmore closely resembles the Necl proteins than JAM
molecules (Garay et al., 2010). Accordingly, CRTAMv indeed ex-
hibits signature characteristics of Necl proteins in sequence (Fig-
ure 7) and ismore phylogenetically related (Figure S2) and shows
better structural similarity to the Necls than to the nectins (Table
2). In this sense, the Necl-2v/CRTAMv structure also represents
a heterodimeric structure of the Necl proteins. Recently, Stengel
and colleagues reported the structure of the TIGIT/Necl-5 heter-
odimer, corresponding to the first of the nectin molecules (Fig-
ure 7; Stengel et al., 2012). Our study, together with Stengel’s
work, therefore provided the prototypic atomic models for heter-
odimeric interactions among the nectin/Necl proteins and the
related molecules.1436 Structure 21, 1430–1439, August 6, 2013 ª2013 Elsevier Ltd AlThe work reported here sheds lights on the immune therapeu-
tics for some autoimmune diseases, such as alopecia (Gian-
greco et al., 2012). Interruption of the CRTAM/Necl-2 complex
by preparation of soluble Necl-2 (possibly selection of a
higher-affinity variant) to block T cell function may inhibit the
overactivation of T cells in this type of autoimmune disease.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification
The cDNAs encoding the first Ig domain of human Necl-2 (residues 45–144)
and human CRTAM (residues 18–117) were subcloned into the NdeI and
XhoI sites of pET21a. Recombinant proteins were expressed in Escherichia
coli strain BL21 (DE3) as inclusion bodies (IBs) that were purified as previously
described (Liu et al., 2010). For in vitro refolding, the individual Necl-2v and
CRTAMv IBs or their equal volume mixture were slowly injected into refolding
buffer (100 mM Tris [pH 8.0], 400 mM L-arginine, 2 mM EDTA, 5 mM reduced
glutathione, and 1 mM oxidized glutathione) to a final concentration of
120mg/l. The refolded protein was then concentrated and purified by gel filtra-
tion on a Hiload 16/60 Superdex 200 PG column (GE Healthcare).
SPR Analysis
The SPR analysis was performed as previously described (Zhang et al., 2011).
In brief, Necl-2v or BSA were immobilized on a CM5 sensor chip (GE Health-
care) using a standard amine coupling method at about 700 response units.
Various concentrations of the WT and mutant CRTAMv proteins were serially
injected over the chips on a BIAcore 3000 system (GE Healthcare). Binding
data were fitted with BIAevaluation software 4.1 using a 1:1 Langmuir binding
mode. All experiments were performed at 25C using a running buffer contain-
ing 10mMHEPES (pH 8.0), 150mMNaCl, 3mMEDTA, and 0.005%Tween 20.
Biochemical Characterization of the Proteins
The analytical gel filtration assay is performed on a calibrated Superdex 75
10/300 GL column (GE Healthcare). Equal volumes of each purified protein
(Necl-2v, CRTAMv, and the Necl-2v/CRTAMv complex) were loaded onto
the column, and their chromatographs were superimposed for comparison.
The ultracentrifugation assay followed the previously reported method
(Zhang et al., 2011). The proteins were prepared in 20 mM Tris (pH 8.0) and
150 mM NaCl at a concentration of A280 = 0.8. The assay was performed on
an optimal XL-A analytical ultracentrifuge (Beckman Coulter, Fullerton, CA)
at a speed of 60,000 rpm.
Tetramer Preparation and Cell Staining
Tetramers for theWT andmutant (F39A, T40A, K50A, Y84A, and FTKY [alanine
mutations of all four amino acids]) CRTAMv proteins were prepared as
described previously (Liu et al., 2012). To confirm the expression profiles of
Necl-2, the HEK293T, P815, NCI-H522, and A549 cell lines were first tested
by western blotting and then stained with CRTAMv tetramer (0.05 mg/ml)
and Necl-2 polyclonal antibody (purchased from LeageneBio, Beijing) and
analyzed with flow cytometry. To further confirm the specific interaction be-
tween Necl-2 and CRTAM, a pEGFP-N1 plasmid with an in-frame Necl-2
genewas transiently transfected into P815 cells and then sortedwith a flow cy-
tometer. The transfectant was stained with WT CRTAMv tetramer and
analyzed with flow cytometry.
To confirm the importance of those structurally defined key interface-resi-
dues in the CRTAM/Necl-2 interaction, surface binding of theWT andCRTAMv
mutants to HEK293T cells was compared using flow cytometry with the indi-
vidual tetramers. Reciprocally, HEK293T cells were blocked with CRTAMv
WT protein or the FTKY quadruple mutant or an irrelevant GST protein for
30 min at a concentration of 200 mg/ml. After blockage, these cells were
stained with WT CRTAMv tetramer.
Cell Conjugate Assay
Conjugate assay was performed as previously described (Liu et al., 2012).
Briefly, 293T cells were first stained with PKH26 (a red-signal dye material)
and CFSE (a blue-signal dye material) (Sigma-Aldrich) separately according
to the manufacturer’s instructions and then blocked with CRTAMv wild-typel rights reserved
Figure 7. Sequence Alignment of the Nectin/Necl Proteins and the Related Molecules
Only the N-terminal IgV-domain sequences are compared. Included in the alignment are Necl-1 to -4 and CRTAM, which apparently form one group (the Necl
group), and nectin-1 to -4, Necl-5, TIGIT, CD96, and CD226 that form another (the nectin group). In either group, a signature lock-and-key interaction could be
identified, representing the main intermonomer contacts in the homo- and/or heterodimer formations. The residues that constitute the ‘‘lock’’ and the ‘‘key’’ are
highlighted by enclosure with the blue and yellow boxes, respectively. In the Necl-2v/CRTAMv complex structure, an extra lock-and-key was identified, where
CRTAM residue F39 acts as the protruding key (marked with a red star). The equivalent amino acid in Necls is a Gln residue and thereby does not support the
formation of another lock-and-key in Necl homodimer interfaces. The residue numbering is based on the sequences of the mature proteins. The arrows indicate b
strands (based on the CRTAM structure).
See also Figure S2.
Structure
Complex Structure of CRTAM with Nectin-like 2or mutant protein or control protein at the concentration of 1 mg/ml for 30 min.
After staining and blockage, these two separately stained cells were mixed
and incubated for 30 min and analyzed with flow cytometry.
Knockdown of Necl-2 by Small Interfering RNA
Anti-Necl-2 siRNA 50-GGCAGAAUCUGUUUACGAATT-30 (sense strand) and
50-UUCGUAAACAUUCUGCCTT-30 (antisense strand), and control siRNA 50-
UUCUCCGAACGUGUCACGUTT-30 (sense strand) and 50-ACGUGACAC
GUUCGGAGAATT-30 (antisense strand) were synthesized at GenePharma
(Shanghai, China). Two hundred picomoles of siRNA were transfected into
293T cells using lipofectamine 2000 according to the manufacturer’s instruc-
tions. The cells were then subjected to the conjugate assay and analyzed for
the percentage of double-stained fraction.
Crystallization, Data Collection, and Structure Determination
Via sitting drop vapor diffusion, crystals of the Necl-2v/CRTAMv complex were
obtained by mixing 1 ml protein (10 mg/ml in 20 mM Tris [pH 8.0] and 50 mM
NaCl) with 1 ml reservoir solution (0.15 M ammonium sulfate, 0.1 M Na-HEPES,
and 20% PEG 4000) at 4C. Diffraction data were collected at the beamline
BL5A (wavelength, 1.00000 A˚) of KEK, Japan, and indexed, integrated, and
scaled with HKL2000 (Otwinowski and Minor, 1997).
The structure was solved by molecular replacement using Phaser (Read,
2001) from the CCP4 program suite (CCP4, 1994) with the structures of
CRTAM (PDB code: 3RBG) and mouse Necl-3 (PDB code: 3M45) as the
search models. Initial restrained rigid-body refinement and manual modelStructure 21, 1430building were performed using REFMAC5 (Murshudov et al., 1997) and
COOT (Emsley and Cowtan, 2004), respectively. Further rounds of refinement
were performed using phenix.refine (Adams et al., 2010), with rigid-body
refinement, isotropic ADP refinement, and TLS refinement. The stereochemi-
cal quality of the final model was assessed with the program PROCHECK
(Laskowski et al., 1993). Data collection, processing, and refinement statistics
are summarized in Table 1.
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Table 2. Structural Comparison of CRTAM with Other Nectin/
Necl Proteins for the IgV-like Domains
CRTAMv (Z score)
Necl-1 16.5
Necl-2 16.5
mNecl-3 16.6
TIGIT 12.0
nectin-1 12.0
nectin-2 13.0
nectin-3 12.9
nectin-4 11.8
Necl-5 8.0
The IgV-domain structure of CRTAMwas aligned to those of other nectin/
Necl proteins using an online pairwise comparison server (DALI) and the
yielded Z scores are listed. PDB selection: Necl-1: 1Z9M (Dong et al.,
2006); Necl-2: 4H5S (this study); mouse Necl-3: 3M45 (Fogel
et al., 2010); TIGIT: 3UDW (Stengel et al., 2012); nectin-1: 3U83
(Zhang et al., 2011); nectin-2: 4DFH (Liu et al., 2012); nectin-3: 4FOM
(Harrison et al., 2012); nectin-4: 4FRW(Harrison et al., 2012); and Necl-
5: 3URO (Zhang et al., 2008).
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